COMMUNIQUÉS West-GlobeNewswire

Allscripts appointed to Health Systems Support Framework
11/09/2018
EPR and shared care record provider secures place on NHS England framework that will give health and care organisations easier, faster access to new technology MANCHESTER, United Kingdom, Sept. 11, 2018 (GLOBE NEWSWIRE [...]
Solon Eiendom ASA – Primary insider notification
11/09/2018
(Oslo, Norway, September 10, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Dukat AS bought 35.000 shares in Solon Eiendom ASA at a price of NOK 29.0293. Following [...]
Shire plc: Rule 2.9 Announcement
11/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 September 2018 [...]
NEOVACS ANNOUNCES THAT ITS PARTNER BIOSENSE GLOBAL HAS EXERCISED ITS OPTION TO ACQUIRE THE EXCLUSIVE LICENCE FOR IFNalpha KINOID TO TREAT LUPUS IN CHINA
11/09/2018
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THAT ITS PARTNER BIOSENSE GLOBAL HAS EXERCISED ITS OPTION TO ACQUIRE THE EXCLUSIVE LICENCE FOR IFNalpha KINOID TO TREAT LUPUS IN CHINA Paris and Boston, 11 [...]
NÉOVACS ANNONCE LA LEVÉE DE L'OPTION DE LICENCE SIGNÉE AVEC BIOSENSE GLOBAL POUR LE DÉVELOPPEMENT EN CHINE DE L'IFNalpha KINOIDE DANS LE LUPUS
11/09/2018
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE LA LEVÉE DE L'OPTION DE LICENCE SIGNÉE AVEC BIOSENSE GLOBAL POUR LE DÉVELOPPEMENT EN CHINE DE L'IFNalpha KINOIDE DANS LE TRAITEMENT DU [...]
Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis
11/09/2018
Global headquarters to be co-located in Geneva alongside Alcon's Europe, Middle East and Africa regional office The listed Alcon company will be incorporated in Fribourg, where Alcon already has significant operations, [...]
Biocartis Group NV: Biocartis Creates New Warrant Plan
11/09/2018
PRESS RELEASE : REGULATED INFORMATION Tuesday, 11 September 2018, 07:00 CEST Biocartis Creates New Warrant Plan Mechelen, Belgium, 11 September 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]
Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program
11/09/2018
BURNABY, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced it has signed an agreement with [...]
CV Sciences, Inc. Achieves Industry’s First Hemp Extract GRAS Self-Affirmation
11/09/2018
First Hemp Extract to Achieve Highly Sought-After Self-Affirmed GRAS Status Designation LAS VEGAS, Sept. 10, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) [...]
Telix Completes Acquisition of Atlab for Prostate Cancer Program
11/09/2018
MELBOURNE, Australia and NANTES, France, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) today announced completion of the acquisition of Atlab Pharma SAS (“Atlab”). The option [...]
North Dakota’s first all-ages free dental care event coming to Bismarck
11/09/2018
Hundreds of volunteers to provide free dental services during Mission of Mercy at Bismarck Event Center, Sept. 28-29 BISMARCK, N.D., Sept. 10, 2018 (GLOBE NEWSWIRE) -- The North Dakota Dental Association and North [...]
SIGA Technologies Awarded BARDA Contract for TPOXX®
10/09/2018
- Contract Valued at Up to $629 Million – - Contract Includes Delivery of Oral and Intravenous (IV) Formulations of TPOXX; Development of IV TPOXX; Post-marketing Activities – NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE [...]
BioSyent Announces Changes to Executive Management
10/09/2018
TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced changes to its Executive Management team: Effective on September 10, 2018, Mr. Alfred D’Souza has [...]
ICU Medical, Inc. to Present at the 2018 Morgan Stanley Global Healthcare Conference
10/09/2018
SAN CLEMENTE, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]
SHIRE ANNOUNCES THE PRICING TERMS AND INCREASE IN THE MAXIMUM TENDER AMOUNT OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES
10/09/2018
SHIRE ANNOUNCES THE PRICING TERMS AND INCREASE IN THE MAXIMUM TENDER AMOUNT OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES Dublin, Ireland – September 10, 2018 –Shire plc (LSE: SHP and [...]
Helix BioPharma Corp. Closes Private Placement
10/09/2018
RICHMOND HILL, Ontario, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP)(FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
BioSig Technologies, Inc. Announces 1-for-2.5 Reverse Stock Split for Pending Uplist to Nasdaq
10/09/2018
Split-Adjusted Common Stock trading under BSGMD on September 11, 2018 Santa Monica, CA, Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM, OTCQB: BSGMD) (“BioSig” or the “Company”), a medical [...]
Clearside Biomedical to Participate in 2018 Janney Healthcare Conference
10/09/2018
ALPHARETTA, Ga., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
PLx Pharma Inc. to Present at Janney Healthcare Conference on September 18
10/09/2018
HOUSTON, Sept. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore™ 325 [...]

Pages